Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 14/20 | 0.65 |
| ▸ | INSR | P06213 | 12/20 | 0.60 |
| ▸ | SYK | P43405 | 2/20 | 0.39 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.39 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2061959 | 0.85 | MET (0.84) | METINSR | |
| SCHEMBL3008394 | 0.84 | MET (0.61) | METINSRSYKMAPK9MAPK10 | |
| SCHEMBL3008387 | 0.82 | MET (0.74) | METINSR | |
| SCHEMBL3009987 | 0.82 | MET (0.58) | METINSRSYKPTK2 | |
| SCHEMBL3009983 | 0.79 | MET (0.61) | METINSRPTK2 | |
| SCHEMBL886721 | 0.79 | MET (0.75) | METINSR | |
| SCHEMBL886149 | 0.79 | MET (1.00) | METINSR | |
| SCHEMBL3014426 | 0.77 | INSR (0.44) | METINSRMAPK9MAPK10PTK2 | |
| SCHEMBL886466 | 0.75 | MET (0.82) | METINSR | |
| SCHEMBL886325 | 0.75 | MET (1.00) | METINSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2222647-A1 | FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS | Cephalon, Inc. (US) | 2010-09-01 | — | — | EP | disclosed |
| WO-2008051547-A1 | FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS | CEPHALON, INC. (US) | 2008-05-02 | — | — | WO | disclosed |